ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) shares fell 2.4% during trading on Friday . The company traded as low as $0.73 and last traded at $0.83. 1,107 shares were traded during trading, a decline of 79% from the average session volume of 5,230 shares. The stock had previously closed at $0.85.
ZIVO Bioscience Trading Down 2.4 %
The business's 50-day moving average price is $0.79 and its 200 day moving average price is $0.77.
Get
ZIVO Bioscience alerts:
Institutional Inflows and Outflows
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC lifted its stake in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent SEC filing.
About ZIVO Bioscience
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Further Reading
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
齐沃生物科学股份有限公司(纳斯达克代码:ZIVOW-GET Rating)的股价在周五的交易中下跌了2.4%。该公司股价低至0.73美元,最新报0.83美元。当日成交量为1,107股,较5,230股的平均日成交量下降79%。该股此前收盘价为0.85美元。
Zivo Bioscience股价下跌2.4%
该业务的50日移动均线价格为0.79美元,200日移动均线价格为0.77美元。
到达
Zivo生物科学警报:
机构资金流入和流出
一家对冲基金最近增持了Zivo Bioscience股票。华平资产管理公司最近提交给美国证券交易委员会的文件显示,该公司在第三季度增持了Zivo Bioscience,Inc.的股票,增持幅度达442.0%。该基金持有84,654股该公司股票,在此期间又购买了69,034股。截至最近提交给美国证券交易委员会的文件,华平资产管理有限公司持有的Zivo Bioscience股份价值51,000美元。
关于Zivo生物科学
(获取评级)
Zivo Bioscience,Inc.是一家总部位于密歇根州的生物技术/AgTech公司,致力于利用从其专有藻类培养物中提取的生物活性化合物的免疫健康和营养益处。正在开发的产品包括用作膳食补充剂和功能性食品配料的天然产品,以及旨在为人类和动物提供医疗和制药益处的创新、生物衍生和合成候选产品,重点是调节免疫和炎症反应。
进一步阅读
- 免费获取StockNews.com关于Zivo生物科学的研究报告(ZIVOW)
- 2个近海钻探公司将大赚一笔
- 未来有望实现两位数上涨的三只史泰博股票
- 投资者能信任消费者来提升美国户外品牌吗?
- 如何购买高收益股利股票
- 甲骨文已表示:股价下跌5%
获得Zivo生物科学日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Zivo Bioscience和相关公司的最新新闻和分析师评级的每日简要摘要。